The [Yellowhammer] documents themselves outline that there are risks to the supply of medicines - but do not set out the detail of how those risks have been mitigated, and what doctors and patients should do to plan for the possibility.

Join the BMA and the BMJ to look at the impact of Brexit on health services across the UK - from workforce and regulation, to reciprocal healthcare and medical research, there’s barely a part of the health service that will be unaffected by the UK’s decision to leave the EU.